Icahn Enterprises L.P.
Icahn Enterprises L.P. (IEP) Financial Performance & Income Statement Overview
Analyze Icahn Enterprises L.P. (IEP) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Icahn Enterprises L.P. (IEP) Income Statement & Financial Overview
View the income breakdown for Icahn Enterprises L.P. IEP across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.17B | $2.51B | $2.22B | $2.64B |
| Cost of Revenue | $2.02B | $2.21B | $2.22B | $2.33B |
| Gross Profit | $154.00M | $217.00M | -$2.00M | $307.00M |
| Gross Profit Ratio | $0.07 | $0.09 | -$0.001 | $0.12 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $201.00M | $205.00M | $202.00M | $183.00M |
| Operating Expenses | $352.00M | $218.00M | $190.00M | $183.00M |
| Total Costs & Expenses | $2.37B | $2.55B | $2.41B | $2.52B |
| Interest Income | $83.00M | $97.00M | $115.00M | $122.00M |
| Interest Expense | $128.00M | $129.00M | $130.00M | $128.00M |
| Depreciation & Amortization | $118.00M | $129.00M | $126.00M | $127.00M |
| EBITDA | -$408.00M | $125.00M | $323.00M | -$227.00M |
| EBITDA Ratio | -$0.19 | $0.05 | $0.15 | -$0.09 |
| Operating Income | -$198.00M | -$44.00M | -$167.00M | $124.00M |
| Operating Income Ratio | -$0.09 | -$0.02 | -$0.08 | $0.05 |
| Other Income/Expenses (Net) | -$456.00M | -$89.00M | $234.00M | -$494.00M |
| Income Before Tax | -$654.00M | -$133.00M | $67.00M | -$482.00M |
| Income Before Tax Ratio | -$0.30 | -$0.05 | $0.03 | -$0.18 |
| Income Tax Expense | -$74.00M | -$23.00M | -$13.00M | $4.00M |
| Net Income | -$422.00M | -$98.00M | $54.00M | -$325.00M |
| Net Income Ratio | -$0.19 | -$0.04 | $0.02 | -$0.12 |
| EPS | -$0.79 | $0.65 | $0.11 | -$0.72 |
| Diluted EPS | -$0.79 | $0.65 | $0.11 | -$0.72 |
| Weighted Avg Shares Outstanding | $523.00M | $505.00M | $477.00M | $450.00M |
| Weighted Avg Shares Outstanding (Diluted) | $523.00M | $505.00M | $477.00M | $450.00M |
The company's financials show resilient growth, with revenue advancing from $2.64B in Q2 2024 to $2.17B in Q1 2025. Gross profit remained healthy with margins at 7% in Q1 2025 compared to 12% in Q2 2024. Operating income hit -$198.00M last quarter, sustaining a consistent -9% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$408.00M. Net income dropped to -$422.00M, while earnings per share reached -$0.79. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan